NCT06550180View on ClinicalTrials.gov

The Additive Analgesic Effects of Transversus Abdominis Plane Block in Abdominoplasty Under Spinal Anaesthesia

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
AbdominoplastySpinal AnaesthesiaTransversus Abdominis Plane Block (TAP Block)
Interventions
DRUG

Spinal anaesthesia group (S)

Spinal anaesthesia is given to all patients in S group. They will receive 20 mg of 0.5% hyperbaric bupivacaine plus 25 microgram fentanyl

DRUG

Subcostal TAP block and spinal anesthesia group (STAP)

patient receive Subcostal TAP block before spinal anesthesia. Patients in STAP group will receive 20 ml of 0.25% isobaric bupivacaine for each side before spinal anesthesia

Trial Locations (1)

Unknown

Egyptian liver hospital, Al Mansurah

All Listed Sponsors
lead

Helwan University

OTHER

NCT06550180 - The Additive Analgesic Effects of Transversus Abdominis Plane Block in Abdominoplasty Under Spinal Anaesthesia | Biotech Hunter | Biotech Hunter